{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:29:47Z","timestamp":1793982587334,"version":"4.8.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes insipidus (DI) is a rare endocrine disease involving antidiuretic hormone (ADH), encompassing both central and nephrogenic causes. Inability to respond to or produce ADH leads to inability of the kidneys to reabsorb water, resulting in hypotonic polyuria and, if lack of hydration, hypernatremia. DI cannot be cured and is an unfamiliar disease process to many clinicians. This diagnosis must be distinguished from primary polydipsia and other causes of hypotonic polyuria. The main branchpoints in pathophysiology depend on the level of ADH pathology: the brain or the kidneys. Prompt diagnosis and treatment are critical as DI can cause substantial morbidity and mortality. The gold standard for diagnosis is a water deprivation test followed by desmopressin administration. There is promising research regarding a new surrogate marker of ADH called copeptin, which may simplify and improve the accuracy in diagnosing DI in the future. Patients with DI require adequate access to water, and there are nuances on treatment approaches depending on whether a patient is diagnosed with central or nephrogenic DI. This article describes a stepwise approach to recognition, diagnosis, and treatment of DI.<\/jats:p>","DOI":"10.3389\/fendo.2024.1479764","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:10:48Z","timestamp":1736313048000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Central and nephrogenic diabetes insipidus: updates on diagnosis and management"],"prefix":"10.3389","volume":"15","author":[{"given":"Kathryn","family":"Flynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Vietor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2021.104093","article-title":"Diabetes insipidus","volume":"50","author":"Christ-Crain","year":"2021","journal-title":"La Presse M\u00e9dicale"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13523","article-title":"Diabetes insipidus: Pathogenesis, diagnosis, and clinical management","volume":"13","author":"Mutter","year":"2021","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4071448","article-title":"Diabetes insipidus after traumatic brain injury","volume":"4","author":"Capatina","year":"2015","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.64207","article-title":"When thirst ceases to exist: A case report and literature review of adipsic diabetes insipidus following coil embolization of a ruptured anterior communicating artery aneurysm","volume":"16","author":"Barnett","year":"2024","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac070","article-title":"Approach to the patient: \u201cUtility of the copeptin assay","volume":"107","author":"Christ-Crain","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000336333","article-title":"Diabetes insipidus \u2013 diagnosis and management","volume":"77","author":"Di Iorgi","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-3-200602070-00007","article-title":"Nephrogenic diabetes insipidus","volume":"144","author":"Sands","year":"2006","journal-title":"Ann Intern Med"},{"key":"B8","article-title":"Diagnostic testing for diabetes insipidus","volume-title":"Endotext","author":"Gubbi","year":"2000"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22633","article-title":"A diagnostic enigma of central versus nephrogenic diabetes insipidus: What does the value of copeptin signify","volume":"14","author":"Shrestha","year":"2022","journal-title":"Cureus"},{"key":"B10","article-title":"Primary polydipsia","volume-title":"StatPearls","author":"Kotagiri","year":"2023"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90825-7","article-title":"Neurogenic disorders of osmoregulation","volume":"72","author":"Robertson","year":"1982","journal-title":"Am J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-73-5-721","article-title":"Recognition of partial defects in antidiuretic hormone secretion","volume":"73","author":"Miller","year":"1970","journal-title":"Ann Intern Med"},{"key":"B13","article-title":"Diagnosis and management of diabetes insipidus","volume":"101","author":"Garofalo","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803760","article-title":"A copeptin-based approach in the diagnosis of diabetes insipidus","volume":"379","author":"Fenske","year":"2018","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12498","article-title":"Diabetes insipidus: A pragmatic approach to management","volume":"13","author":"Priya","year":"2021","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cen.13866","article-title":"Diagnosis and management of central diabetes insipidus in adults","volume":"90","author":"Garrahy","year":"2019","journal-title":"Clin Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.02.006","article-title":"Diabetes insipidus in infants and children","volume":"30","author":"Dabrowski","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02191-2","article-title":"Challenges and improvement needs in the care of patients with central diabetes insipidus","volume":"17","author":"Teare","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B19","volume-title":"Desmopressin acetate tablets, Highlights of prescribing information","year":"2019"},{"key":"B20","volume-title":"Desmopressin acetate nasal spray","year":"2018"},{"key":"B21","volume-title":"Nocdurna (desmopressin acetate) sublingual tablets","year":"2018"},{"key":"B22","volume-title":"Desmopressin acetate injection 4mcg\/mL","year":"2020"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.06.002","article-title":"Thiazide diuretics in the management of young children with central diabetes insipidus","volume":"167","author":"Al Nofal","year":"2015","journal-title":"J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00424.2009","article-title":"Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment","volume":"298","author":"Blount","year":"2010","journal-title":"Am J Physiol.-Renal Physiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1980.tb09726.x","article-title":"Renal concentrating capacity in long-term lithium treatment and after withdrawal of lithium","volume":"207","author":"Bucht","year":"1980","journal-title":"Acta Med Scand"},{"key":"B26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12882-018-1101-4","article-title":"Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification","volume":"19","author":"Davis","year":"2018","journal-title":"BMC Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2006.03.004","article-title":"Acquired nephrogenic diabetes insipidus","volume":"26","author":"Khanna","year":"2006","journal-title":"Semin Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy027","article-title":"Long-term outcome in inherited nephrogenic diabetes insipidus","volume":"12","author":"Sharma","year":"2019","journal-title":"Clin Kidney J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00550","article-title":"Diagnosis, treatment, and outcomes in children with congenital nephrogenic diabetes insipidus: a pediatric nephrology research consortium study","volume":"7","author":"D'Alessandri-Silva","year":"2020","journal-title":"Front Pediatr"},{"key":"B30","first-page":"85","article-title":"Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan","volume":"57","author":"Fujimoto","year":"2014","journal-title":"Yonago Acta Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2008.03.010","article-title":"Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus","volume":"28","author":"Bouley","year":"2008","journal-title":"Semin Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7412.1000225","article-title":"Hereditary nephrogenic diabetes insipidus: molecular basis of the defect and potential novel strategies for treatment","volume":"5","author":"Procino","year":"2014","journal-title":"J Genet Syndr Gene Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2018.09.006","article-title":"Nephrogenic diabetes insipidus","volume":"66","author":"Kavanagh","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104657","article-title":"The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus","volume":"41","author":"Earley","year":"1962","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199012000-00026","article-title":"Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate","volume":"83","author":"Weinstock","year":"1990","journal-title":"South Med J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199103213241215","article-title":"Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP","volume":"324","author":"Stasior","year":"1991","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-4-407","article-title":"Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy","volume":"13","author":"Kamath","year":"2013","journal-title":"Clin Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.02.005","article-title":"Ifosfamide-induced Fanconi syndrome and desmopressin-responsive nephrogenic diabetes insipidus","volume":"126","author":"Kamran","year":"2013","journal-title":"Am J Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2019.270","article-title":"Lithium-induced nephrogenic diabetes insipidus responsive to desmopressin","volume":"15","author":"Ta\u015f\u00e7i","year":"2019","journal-title":"Acta Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5414\/cncs110589","article-title":"Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin","volume":"9","author":"Sohail","year":"2021","journal-title":"Clin Nephrol Case Stud"},{"key":"B42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000070629","article-title":"Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin","volume":"59","author":"Mizuno","year":"2003","journal-title":"Horm Res Paediatr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.2021-0032","article-title":"Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report","volume":"31","author":"Ikegawa","year":"2022","journal-title":"Clin Pediatr Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900130106","article-title":"Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists","volume":"106","author":"Robben","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2008121289","article-title":"Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus","volume":"20","author":"Jean-Alphonse","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112385","article-title":"Hereditary nephrogenic diabetes insipidus: pathophysiology and possible treatment","volume":"18","author":"Milano","year":"2017","journal-title":"update Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00337.2004","article-title":"Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra)","volume":"288","author":"Bouley","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000439065","article-title":"Sildenafil for the treatment of congenital nephrogenic diabetes insipidus","volume":"42","author":"Assadi","year":"2015","journal-title":"Am J Nephrol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1038\/ki.2014.409","article-title":"Statins in the prevention of lithium-associated diabetes insipidus: preliminary findings","volume":"23","author":"Elie","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142013","article-title":"An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus","volume":"6","author":"Klein","year":"2021","journal-title":"JCI Insight"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00339.2020","article-title":"mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus","volume":"319","author":"Mortensen","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00001.2011","article-title":"Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase","volume":"301","author":"Li","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.10","article-title":"Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice","volume":"86","author":"Procino","year":"2014","journal-title":"Kidney Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00102.2016","article-title":"Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts","volume":"310","author":"Klein","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra1404489","article-title":"Disorders of plasma sodium\u2013causes, consequences, and correction","volume":"372","author":"Sterns","year":"2015","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1159\/000168630","article-title":"Treatment of acute hypernatremia with hemodialysis","volume":"13","author":"Pazmi\u00f1o","year":"1993","journal-title":"Am J Nephrol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00034.2004","article-title":"Cellular volume homeostasis","volume":"28","author":"Strange","year":"2004","journal-title":"Adv Physiol Educ"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.01730","article-title":"Organic osmolytes as compatible, metabolic, and counteracting cytoprotectants in high osmolarity and other stresses","volume":"208","author":"Yancey","year":"2005","journal-title":"J Exp Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2010.01712.x","article-title":"Fluid management of hypernatraemic dehydration to prevent cerebral oedema: a retrospective case control study of 97 children in China","volume":"46","author":"Fang","year":"2010","journal-title":"J Paediatr Child Health"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1479764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:10:54Z","timestamp":1736313054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1479764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":62,"alternative-id":["10.3389\/fendo.2024.1479764"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1479764","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"article-number":"1479764"}}